113 related articles for article (PubMed ID: 10501503)
1. A recombinant human papillomavirus (HPV) type 16 L1-vaccinia virus murine challenge model demonstrates cell-mediated immunity against HPV virus-like particles.
Marais D; Passmore JA; Maclean J; Rose R; Williamson AL
J Gen Virol; 1999 Sep; 80 ( Pt 9)():2471-2475. PubMed ID: 10501503
[TBL] [Abstract][Full Text] [Related]
2. Enhanced mucosal and systemic immune responses following intravaginal immunization with human papillomavirus 16 L1 virus-like particle vaccine in thermosensitive mucoadhesive delivery systems.
Park JS; Oh YK; Kang MJ; Kim CK
J Med Virol; 2003 Aug; 70(4):633-41. PubMed ID: 12794729
[TBL] [Abstract][Full Text] [Related]
3. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Pinto LA; Edwards J; Castle PE; Harro CD; Lowy DR; Schiller JT; Wallace D; Kopp W; Adelsberger JW; Baseler MW; Berzofsky JA; Hildesheim A
J Infect Dis; 2003 Jul; 188(2):327-38. PubMed ID: 12854090
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice.
Nardelli-Haefliger D; Roden RB; Benyacoub J; Sahli R; Kraehenbuhl JP; Schiller JT; Lachat P; Potts A; De Grandi P
Infect Immun; 1997 Aug; 65(8):3328-36. PubMed ID: 9234794
[TBL] [Abstract][Full Text] [Related]
5. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
6. Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine.
Emeny RT; Wheeler CM; Jansen KU; Hunt WC; Fu TM; Smith JF; MacMullen S; Esser MT; Paliard X
J Virol; 2002 Aug; 76(15):7832-42. PubMed ID: 12097595
[TBL] [Abstract][Full Text] [Related]
7. Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: immunogenicity and protective efficacy in macaques.
Dale CJ; Liu XS; De Rose R; Purcell DF; Anderson J; Xu Y; Leggatt GR; Frazer IH; Kent SJ
Virology; 2002 Sep; 301(1):176-87. PubMed ID: 12359458
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast.
Lowe RS; Brown DR; Bryan JT; Cook JC; George HA; Hofmann KJ; Hurni WM; Joyce JG; Lehman ED; Markus HZ; Neeper MP; Schultz LD; Shaw AR; Jansen KU
J Infect Dis; 1997 Nov; 176(5):1141-5. PubMed ID: 9359711
[TBL] [Abstract][Full Text] [Related]
9. Comparison of human papillomavirus type 16 L1 chimeric virus-like particles versus L1/L2 chimeric virus-like particles in tumor prevention.
Wakabayashi MT; Da Silva DM; Potkul RK; Kast WM
Intervirology; 2002; 45(4-6):300-7. PubMed ID: 12566713
[TBL] [Abstract][Full Text] [Related]
10. Improved efficiency of a Salmonella-based vaccine against human papillomavirus type 16 virus-like particles achieved by using a codon-optimized version of L1.
Baud D; Ponci F; Bobst M; De Grandi P; Nardelli-Haefliger D
J Virol; 2004 Dec; 78(23):12901-9. PubMed ID: 15542642
[TBL] [Abstract][Full Text] [Related]
11. Papillomavirus-like particles for serology and vaccine development.
Kirnbauer R
Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of human papillomavirus type 11 (HPV-11) by serum from women vaccinated with yeast-derived HPV-11 L1 virus-like particles: correlation with competitive radioimmunoassay titer.
Brown DR; Bryan JT; Schroeder JM; Robinson TS; Fife KH; Wheeler CM; Barr E; Smith PR; Chiacchierini L; DiCello A; Jansen KU
J Infect Dis; 2001 Nov; 184(9):1183-6. PubMed ID: 11598842
[TBL] [Abstract][Full Text] [Related]
13. [Possibilities of vaccination against HPV infections in cervix carcinoma].
Gissmann L
Zentralbl Gynakol; 2001 May; 123(5):299-301. PubMed ID: 11449623
[TBL] [Abstract][Full Text] [Related]
14. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies.
Hagensee ME; Carter JJ; Wipf GC; Galloway DA
Virology; 1995 Jan; 206(1):174-82. PubMed ID: 7530391
[TBL] [Abstract][Full Text] [Related]
15. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
[TBL] [Abstract][Full Text] [Related]
16. Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine.
Jochmus I; Schäfer K; Faath S; Müller M; Gissmann L
Arch Med Res; 1999; 30(4):269-74. PubMed ID: 10573627
[TBL] [Abstract][Full Text] [Related]
17. Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector.
Gao L; Chain B; Sinclair C; Crawford L; Zhou J; Morris J; Zhu X; Stauss H
J Gen Virol; 1994 Jan; 75 ( Pt 1)():157-64. PubMed ID: 7509369
[TBL] [Abstract][Full Text] [Related]
18. Enhanced mucosal and systemic immunogenicity of human papillomavirus-like particles encapsidating interleukin-2 gene adjuvant.
Oh YK; Sohn T; Park JS; Kang MJ; Choi HG; Kim JA; Kim WK; Ko JJ; Kim CK
Virology; 2004 Oct; 328(2):266-73. PubMed ID: 15464846
[TBL] [Abstract][Full Text] [Related]
19. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
[TBL] [Abstract][Full Text] [Related]
20. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16.
He Z; Wlazlo AP; Kowalczyk DW; Cheng J; Xiang ZQ; Giles-Davis W; Ertl HC
Virology; 2000 Apr; 270(1):146-61. PubMed ID: 10772987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
